hrcak mascot   Srce   HID

Stručni rad

GUIDELINES FOR DIAGNOSTICS AND TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA IN ADULTS

Silva Zupančić-Šalek
Dražen Pulanić
Slobodanka Ostojić-Kolonić
Vlatko Pejša
Toni Valković
Damir Nemet

Puni tekst: hrvatski, pdf (811 KB) str. 0-0 preuzimanja: 660* citiraj
APA 6th Edition
Zupančić-Šalek, S., Pulanić, D., Ostojić-Kolonić, S., Pejša, V., Valković, T. i Nemet, D. (2017). SMJERNICE ZA DIJAGNOSTIKU I LIJEČENJE PRIMARNE IMUNOSNE TROMBOCITOPENIJE U ODRASLIH. Liječnički vjesnik, 139 (7-8), 0-0. Preuzeto s https://hrcak.srce.hr/189745
MLA 8th Edition
Zupančić-Šalek, Silva, et al. "SMJERNICE ZA DIJAGNOSTIKU I LIJEČENJE PRIMARNE IMUNOSNE TROMBOCITOPENIJE U ODRASLIH." Liječnički vjesnik, vol. 139, br. 7-8, 2017, str. 0-0. https://hrcak.srce.hr/189745. Citirano 16.10.2019.
Chicago 17th Edition
Zupančić-Šalek, Silva, Dražen Pulanić, Slobodanka Ostojić-Kolonić, Vlatko Pejša, Toni Valković i Damir Nemet. "SMJERNICE ZA DIJAGNOSTIKU I LIJEČENJE PRIMARNE IMUNOSNE TROMBOCITOPENIJE U ODRASLIH." Liječnički vjesnik 139, br. 7-8 (2017): 0-0. https://hrcak.srce.hr/189745
Harvard
Zupančić-Šalek, S., et al. (2017). 'SMJERNICE ZA DIJAGNOSTIKU I LIJEČENJE PRIMARNE IMUNOSNE TROMBOCITOPENIJE U ODRASLIH', Liječnički vjesnik, 139(7-8), str. 0-0. Preuzeto s: https://hrcak.srce.hr/189745 (Datum pristupa: 16.10.2019.)
Vancouver
Zupančić-Šalek S, Pulanić D, Ostojić-Kolonić S, Pejša V, Valković T, Nemet D. SMJERNICE ZA DIJAGNOSTIKU I LIJEČENJE PRIMARNE IMUNOSNE TROMBOCITOPENIJE U ODRASLIH. Liječnički vjesnik [Internet]. 2017 [pristupljeno 16.10.2019.];139(7-8):0-0. Dostupno na: https://hrcak.srce.hr/189745
IEEE
S. Zupančić-Šalek, D. Pulanić, S. Ostojić-Kolonić, V. Pejša, T. Valković i D. Nemet, "SMJERNICE ZA DIJAGNOSTIKU I LIJEČENJE PRIMARNE IMUNOSNE TROMBOCITOPENIJE U ODRASLIH", Liječnički vjesnik, vol.139, br. 7-8, str. 0-0, 2017. [Online]. Dostupno na: https://hrcak.srce.hr/189745. [Citirano: 16.10.2019.]

Sažetak
Working Group for Diseases of Hemostasis and Thrombosis of the Croatian Cooperative Group for Hematologic Diseases (CROHEM), Referral Center for Hereditary and Acquired Disorders of Hemostasis of the Croatian Ministry of Health, and Croatian Hematology Society of the Croatian Medical Association developed the Croatian guidelines for the diagnosis and treatment of primary immune thrombocytopenia (ITP). Detailed clinical and laboratory examination should be performed to exclude common secondary causes of thrombocytopenia. An individualized therapeutic approach is ­proposed, and decision to start active treatment depends on the severity and risk of bleeding, platelet count, patient’s life style, age and comorbidities. Glucocorticoids with or without intravenous immunoglobulines are recommended as the first line treatment. The second line treatments are splenectomy or thrombopoietin receptor agonists as suggested options. Thrombopoietin receptor agonists are recommended treatment for splenectomized patients with relapsed ITP. Alternatively rituximab or other immunosuppressive agents are suggested in second or later treatment lines.

Ključne riječi
Purpura, thrombocytopenic, idiopathic – diagnosis, drug therapy, surgery; Adrenal cortex hormones – therapeutic use; Immunoglobulins, intravenous – therapeutic use; Receptors, thrombopoietin – agonists; Rituximab – terapeutic use; Splenectomy; Practice guidelines as topic

Hrčak ID: 189745

URI
https://hrcak.srce.hr/189745

[hrvatski]

Posjeta: 768 *